Table 2.

Change in Outcomes in Treated Cases and Observed Controls

	Observed Controls (95% Confidence Intervals)	Treated Cases (95% Confidence Intervals)	P Value
Change in BCVA at:
1 mo	−0.6 (−1.6 to 0.4)	1.2 (0.07 to 2.3)	0.15
3 mo	−0.3 (−1.7 to 1.1)	2.2 (0.8 to 3.6)	0.12
Change in CMT at:
1 mo	−24.1 (−34.0 to −14.2)	−94.3 (−131.4 to −57.7)	0.008
3 mo	−45.1 (−65.3 to −25.1)	−145.6 (−170.5 to −120.7)	0.015
% achieved complete resolution at 3 mo	6 (40.0%)	14 (77.8%)	0.04
Change in IOP at:
1 mo	1.1 (0.2 to 1.9)	−2.9 (−4.0 to −1.8)	0.0009
3 mo	0.9 (−0.06 to 1.9)	−2.4 (−3.5 to −1.3)	0.003
Change in choroidal thickness at:
1 mo	0.8 (−4.4 to 6.0)	−13.3 (−25.1 to −1.5)	0.20
3 mo	−0.6 (−6.3 to 5.1)	−13.4 (−25.1 to −1.7)	0.24

BCVA, best corrected visual acuity; CMT, central macular thickness; IOP, intraocular pressure; SD, standard deviation.